|
| 37438856 | Children's Oncology Group's 2023 blueprint for research: Young investigators. | | 2023 |
| 36521378 | Primary central nervous system germ cell tumors in children and young adults: A review of controversies in diagnostic and treatment approach. | Neoplasia | 2023 |
| 37204254 | Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy. | Oncotarget | 2023 |
| 37010875 | Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. | Neuro Oncol | 2023 |
| 36548930 | Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. | J Clin Oncol | 2023 |
| 34724065 | EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults. | Neuro Oncol | 2022 |
| 35373903 | Photon versus proton whole ventricular radiotherapy for non-germinomatous germ cell tumors: A report from the Children's Oncology Group. | Pediatric Blood and Cancer | 2022 |
| 35489353 | Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group. | Lancet Oncol | 2022 |
| 36497477 | Magnetic Resonance Spectroscopy Metabolites as Biomarkers of Disease Status in Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) Treated with Glioma-Associated Antigen Peptide Vaccines. | Cancers (Basel) | 2022 |
| 34990779 | A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors. | Int J Radiat Oncol Biol Phys | 2022 |
| 35307742 | Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. | Neuro Oncol | 2022 |
| 35218656 | Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials. | Neuro Oncol | 2022 |
| 34850169 | Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children's Oncology Group study. | Neuro Oncol | 2022 |
| 34605541 | Potential role of carbon ion radiotherapy in chromothripsis-induced medulloblastoma and other malignancies. | Neuro-Oncology | 2021 |
| 34125480 | Multi-institutional analysis of treatment modalities in basal ganglia and thalamic germinoma. | Pediatr Blood Cancer | 2021 |
| 33480656 | Primary Primitive Neuroectodermal Tumor of the Spine With t(11;22): Report of 3 Cases and Review of Literature. | J Pediatr Hematol Oncol | 2021 |
| 33948563 | Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults. | Neurooncol Adv | 2021 |
| 33502920 | Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. | J Clin Oncol | 2021 |
| 33356006 | How to be successful in an academic interview in pediatric oncology: A survey of Children's Oncology Group (COG) and International Society of Paediatric Oncology (SIOP) mentors. | Pediatric Blood and Cancer | 2021 |
| 33405376 | A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042). | Pediatr Blood Cancer | 2021 |
| 33163308 | Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series. | Cureus | 2020 |
| 31850678 | Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experience. | Pediatr Blood Cancer | 2020 |
| 32187454 | Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience. | Pediatr Blood Cancer | 2020 |
| 31951480 | Primary diffuse leptomeningeal glioneuronal tumors of the central nervous system: Report of three cases and review of literature. | Pediatr Hematol Oncol | 2020 |
| 32304218 | Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trial. | Neuro Oncol | 2020 |
| 32297094 | Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature. | J Neurooncol | 2020 |
| 32342334 | Epigenetics impacts upon prognosis and clinical management of choroid plexus tumors. | Journal of Neuro-Oncology | 2020 |
| 32537181 | Neuropsychological outcomes on Head Start III: a prospective, multi-institutional clinical trial for young children diagnosed with malignant brain tumors. | Neurooncol Pract | 2020 |
| 32523649 | Phase I study of vemurafenib in children with recurrent or progressive BRAF<sup>V600E</sup> mutant brain tumors: Pacific Pediatric Neuro-Oncology Consortium study (PNOC-002). | Oncotarget | 2020 |
| 32502459 | Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. | Lancet Oncol | 2020 |
| 31545689 | Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study. | J Clin Oncol | 2019 |
| 31621042 | Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens. | J Neurooncol | 2019 |
| 31502379 | Clinical and neuropsychological outcome of pediatric non-midline central nervous system germinoma treated with chemotherapy and reduced dose/volume irradiation: The Children's Hospital Los Angeles experience. | Pediatr Blood Cancer | 2019 |
| 30728904 | Sustained response of three pediatric BRAF<sup>V600E</sup> mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy. | Oncotarget | 2019 |
| 30885981 | Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma. | Cancer Res | 2019 |
| 31151904 | Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. | Lancet Oncol | 2019 |
| 31309744 | Mentors' perspectives on the successes and challenges of mentoring in the COG Young Investigator mentorship program: A report from the Children's Oncology Group. | Pediatr Blood Cancer | 2019 |
| 31535450 | The relationship between ventricular volume and whole-brain irradiation dose in central nervous system germ cell tumors. | Pediatric Blood and Cancer | 2019 |
| 29189102 | Changes in Signal Intensity of the Dentate Nucleus and Globus Pallidus in Pediatric Patients: Impact of Brain Irradiation and Presence of Primary Brain Tumors Independent of Linear Gadolinium-based Contrast Agent Administration. | Radiology | 2018 |
| 30173409 | A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group. | J Neurooncol | 2018 |
| 29989524 | Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity. | Radiology | 2018 |
| 29750396 | A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. | Pediatr Blood Cancer | 2018 |
| 29427149 | Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors. | J Neurooncol | 2018 |
| 29581140 | Transmission of a <i>TP53</i> germline mutation from unaffected male carrier associated with pediatric glioblastoma in his child and gestational choriocarcinoma in his female partner. | Cold Spring Harb Mol Case Stud | 2018 |
| 29193588 | Long-term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology Group. | Pediatric Blood and Cancer | 2018 |
| 27808466 | Vincristine and Vinblastine: Is checking bilirubin mandatory in children with Brain Tumors? | Pediatr Blood Cancer | 2017 |
| 28379644 | Radiotherapy after high-dose chemotherapy with autologous hematopoietic cell rescue: Quality assessment of Head Start III. | Pediatr Blood Cancer | 2017 |
| 28405869 | Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach. | J Neurooncol | 2017 |
| 28475292 | Long-term follow-up of endocrine function among young children with newly diagnosed malignant central nervous system tumors treated with irradiation-avoiding regimens. | Pediatr Blood Cancer | 2017 |
| 28783147 | Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors. | Bone Marrow Transplant | 2017 |